Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
30.99
+0.35 (1.14%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $3.32 billion as of April 28, 2026. Its market cap has increased by 176.86% in one year.
Market Cap
3.32B
Enterprise Value
2.80B
1-Year Change
176.86%
Ranking
Category
Stock Price
$30.99
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $3.32B, an increase of 336.79%. That is a compound annual growth rate of 33.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.33B | 26.62% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Travere Therapeutics | 3.74B |
| Tango Therapeutics | 3.72B |
| Telix Pharmaceuticals | 3.61B |
| Oruka Therapeutics | 3.47B |
| NewAmsterdam Pharma Company | 3.42B |
| Catalyst Pharmaceuticals | 3.34B |
| Structure Therapeutics | 3.22B |
| Arcus Biosciences | 3.20B |